National Institutes of Health

Description

This funding opportunity announcement (FOA) solicits research grant applications from organizations that propose to conduct human tissue- and cell-based vascular research. The primary goal of this initiative is to promote research that will advance translational efforts in lung vascular disease. This program makes available human biospecimens collected by the Pulmonary Hypertension Breakthrough Initiative (PHBI). Biospecimens may be used to investigate mechanistic research questions in lung vascular biology, including validating hypotheses of pulmonary arterial hypertension (PAH) pathogenesis. Innovative use of biospecimens for addressing general vascular biology research questions is encouraged.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV